COVID-19 vaccination produces a more consistent immune response than a past infection. With the delta variant, the difference in protection may be even greater.
If you’ve already had the coronavirus and recovered, you might be tempted to give the vaccine a pass. A scientist explains why the shot offers the best protection against future infection.
Michael Plank, University of Canterbury and Shaun Hendy, University of Auckland, Waipapa Taumata Rau
A new study argues for selective border relaxations. But with COVID-19 more prevalent now than at almost any point in the past, the risk would be substantial.
Healing is a complicated process. As people age, higher rates of disease and the fact that old cells lose the ability to divide slow this process down.
Communication between programmers and local communities can provide good opportunities in the toilet prototyping process from the beginning of the design process.
Zoë McLaren, University of Maryland, Baltimore County
COVID-19 cases are skyrocketing across the US. Testing has ramped up over the past few months, but increasing hospitalizations, deaths and test-positivity rates show that the virus is out of control.
Resistant bacteria aren’t the only risk posed by overprescribing antibiotics. A more immediate risk is side-effects and reactions, which a new review shows are surprisingly frequent and often severe.
Michael Gurven, University of California, Santa Barbara and Thomas Kraft, University of California, Santa Barbara
‘Normal’ body temperature has declined in urban, industrialized settings like the US and UK. Anthropologists find the trend extends to Indigenous people in the Bolivian Amazon – but why?
Widely adopted in the US when pandemic precautions kept people home, telehealth faces a challenge as insurance coverage changes, right when its popularity had surged.
Scientists in the UK and Germany discovered a new doorway that the COVID-19 virus uses to infect human cells. This reveals new therapeutic possibilities for blocking the virus.
Over the approaching holidays, people around the world will want to travel to see friends and family. Getting tested for the coronavirus can make this safer, but testing alone is not a perfect answer.
Patients suffering from severe COVID-19 may be experiencing a rogue antibody response similar to that seen in autoimmune diseases. The findings offer new approaches for COVID-19 therapy.
The pandemic has exposed many of us to new statistical concepts, on the news, in everyday conversations and on social media. But how many are you getting wrong?